The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Official Title: An Observational Cohort Study on Transplant-Related Mortality in Patients Receiving Either a Hematopoietic Stem Cell Transplantation Without ATIR or an Umbilical Cord Blood Transplantation
Study ID: NCT02188290
Brief Summary: Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Algemeen Ziekenhuis Sint-Jan, Brugge, , Belgium
Institut Jules Bordet, Brussels, , Belgium
Universitair Ziekenhuis Gasthuisberg, Leuven, , Belgium
Hamilton Niagara Regional Haemophilia Centre, Hamilton, Ontario, Canada
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
Universitätsklinikum Würzburg, Würzburg, , Germany
Academisch Ziekenhuis Maastricht, Maastricht, , Netherlands
Hammersmith Hospital, London, , United Kingdom
Name: Jeroen Rovers, MD
Affiliation: Kiadis Pharma
Role: STUDY_CHAIR